CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 573 enrolled
Drug / intervention
ELECTROCARDIOGRAM (ECG) PATCH WEARdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04699812
NCT04699812N/ACompleted

Atrial Fibrillation Algorithms Clinical Validation Study

Apple Inc.·interventional·Posted Jan 7, 2021·Updated Aug 24, 2022

In Brief

A clinical study evaluating ELECTROCARDIOGRAM (ECG) PATCH WEAR for Atrial Fibrillation. Completed, enrolled 573 participants across 4 sites.

Detailed Summary

The purpose of the study is to evaluate the performances of investigational Irregular Rhythm Notification Feature (version 2.0) and Atrial Fibrillation History Feature algorithms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsIQVIA Pty Ltd

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 7, 2021
Enrollment StartNov 16, 2020
Primary CompletionApr 19, 2021
Study CompletionDec 17, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.5 years ago

Interventions

ELECTROCARDIOGRAM (ECG) PATCH WEARdevice

ALL PARTICIPANTS WILL WEAR AN ECG PATCH ON THEIR UPPER LEFT CHEST THROUGHOUT THE STUDY PARTICIPATION